Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Outset Medical (OM) Operating Expenses (2019 - 2026)

Outset Medical has reported Operating Expenses over the past 7 years, most recently at $29.9 million for Q4 2025.

  • Quarterly Operating Expenses fell 8.42% to $29.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $113.5 million through Dec 2025, down 25.33% year-over-year, with the annual reading at $113.5 million for FY2025, 25.33% down from the prior year.
  • Operating Expenses was $29.9 million for Q4 2025 at Outset Medical, up from $27.4 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $52.6 million in Q3 2023 and troughed at $27.4 million in Q3 2025.
  • The 5-year median for Operating Expenses is $40.7 million (2022), against an average of $39.1 million.
  • Year-over-year, Operating Expenses surged 80.01% in 2021 and then crashed 39.14% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $44.1 million in 2021, then rose by 2.21% to $45.1 million in 2022, then dropped by 0.07% to $45.1 million in 2023, then decreased by 27.64% to $32.6 million in 2024, then fell by 8.42% to $29.9 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Operating Expenses are $29.9 million (Q4 2025), $27.4 million (Q3 2025), and $28.7 million (Q2 2025).